StonvexLoading…
StonvexCore line items from S's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-28 | Annual 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $282.85M | $1.00B | $730.13M | $471.21M | $229.03M |
Operating Income | Not available | $-321.31M | $-241.41M | $-168.10M | $-87.48M |
Net Income | Not available | $-450.74M | $-340.50M | $-280.21M | $-208.19M |
EPS (Diluted) | $0.02 | $-1.37 | $-1.04 | $-0.85 | $-0.63 |
Total Assets | Not available | $2.44B | $2.43B | $2.35B | $2.38B |
Total Liabilities | Not available | $1.00B | $882.05M | $842.70M | $837.41M |
Cash & Equivalents | Not available | $169.63M | $150.21M | $278.00M | $188.62M |
Free Cash Flow OCF − CapEx | Not available | $75.90M | $71.73M | $50.82M | $52.13M |
Shares Outstanding | Not available | 330.11M | 328.52M | 329.48M | 327.98M |